KZIA Kazia Therapeutics Limited
Healthcare$13.66+3.72%ClosedMarket Cap: $22.1M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
1.28
P/S
1565.80
EV/EBITDA
2.12
DCF Value
$-0.59
FCF Yield
-29.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
100.0%
Operating Margin
-92086.4%
Net Margin
-113004.6%
ROE
-116.9%
ROA
-31.4%
ROIC
-36.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 null | $0.00 | NaN% | $-13.3M | $-12.3M | $— | — |
| Q4 null | $19.7K | 100.0% | $-4.8M | $-10.0M | $— | — |
| FY null | $42.0K | 100.0% | $-14.2M | $-20.7M | $— | — |
| Q2 null | $22.3K | 100.0% | $-9.4M | $-10.5M | $— | — |
| Q4 null | $2.5M | 100.0% | $-19.6M | $-18.0M | $— | — |
| FY null | $2.3M | 100.0% | $-28.5M | $-26.8M | $— | — |
| Q2 null | $5.00 | 100.0% | $-8.9M | $-8.8M | $— | — |
| Q4 null | $1.0K | 100.0% | $-10.5M | $-6.9M | $— | — |
| FY null | $555.00 | 100.0% | $-24.1M | $-20.5M | $— | — |
| Q2 null | $0.00 | NaN% | $-13.6M | $-13.6M | $— | — |
| Q4 null | $0.00 | NaN% | $-25.4M | $-11.8M | $— | — |
| FY null | $10.0K | 100.0% | $-25.4M | $-25.0M | $— | — |